A randomized, placebo-controlled, phase 3 study of the safety and efficacy of solriamfetol (JZP-110) for the treatment of excessive sleepiness in patients with narcolepsy
| Autor: | Thorpy, M.J., Dauvilliers, Y., Shapiro, C., Mayer, G., Corser, B.C., Chen, D., Li, J., Carter, L.P., Wang, H., Black, J., Emsellem, H. |
|---|---|
| Zdroj: | In Sleep Medicine December 2017 40 Supplement 1:e327-e327 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect